Latex Allergy Market Information, by exposure type (latex gloves, food containing latex substances, others), by diagnosis type (skin test, allergy test), by reaction type (Systemic Reaction, Allergic contact dermatitis, others), by treatment type (Epinephrine injection, Allergy medication), by region type – Forecast to 2027
The global latex allergy market key players is expected to grow with a steady CAGR during the forecast period (2016-2022), claims Market Research Future (MRFR) in a well-studied report. Exposure to substances made of latex (natural rubber) can trigger an allergy in a person by directly affecting that person’s immune system. This leads to the release of antibodies and antihistamines which causes itchy hands, skin rash, hives, and eczema. People who use it continually may find this type of allergy troubling them more. For instance, workers in the healthcare industry can get affected by this disease more than the regular populace. A study by Centers for Disease Control and Prevention reveals, 8 to 12% of healthcare workers are susceptible to this allergy, compared with 1 to 6% of the general population. This type of allergy can further enhance the chances of people getting affected by diseases such as Asthma, Rhinitis, Anaphylaxis, and others.
However, the disease can turn fatal if the allergy causes anaphylaxis. Signs will be numerous. Only an appropriate measure can keep it in check.
Some of the key players in this market are: 3M (USA), Alcon Inc. (US), Allerayde UK Ltd (UK), Allergy Hero (UK), Array BioPharma Inc. (US), AstraZeneca (UK), Aterica (Canada), Boehringer-Ingelheim (Germany), Dey Labs (US), GlaxoSmithKline (UK), Johnson Johnson (US), Merck (US), Nektar Therapeutics (US), Novartis AG (Switzerland), Rocky Mountain Diagnostics (US), Sanofi (France), and others.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/1693
The global latex allergy market can be segmented by exposure type, diagnosis type, reaction type, and treatment.
Based on of exposure the market is segmented as latex gloves, food containing latex substances.
Diagnosis-type consists diagnosis type the market is segmented as skin test and allergy test.
On the basis of reaction type, the market is segmented into the systemic reaction, allergic contact dermatitis, irritant contact dermatitis, asthma, anaphylaxis, and rhinitis.
Type-based segmentation requires epinephrine injection, allergy medications: inhaler/albuterol, antihistamine, asthma medication, corticosteroids, etc.
Geographically, the global latex allergy market envelops North America, Asia Pacific (APAC), Europe, and the Middle East Africa (MEA).
North America has taken a considerable lead in the global market by generating the maximum revenue share. Major pharmaceutical companies are based out of the U.S. owing to which the regional market is prospering. In addition, awareness related to such diseases and technological advancements in the healthcare sector coupled with the availability of possible alternatives to reduce the use of latex spur the market growth.
The APAC is expected to be one of the most significant regions. The huge population base is a major reason driving the market ahead. At the same time, the healthcare segment is also getting definite boosting.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/latex-allergy-market-1693
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Market Research Future
+1 646 845 9312
Email: [email protected]